Neonatal adrenoleucodystrophy
A rare metabolic disorder that affects neonates. It is characterized by damage of the white matter in the brain and degeneration of the adrenal glands. It manifests with hyperactivity, paralysis, muscular weakness, crossed eyes, hearing loss, seizures, and coma.
E71.511 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM E71.511 became effective on October 1, 2022.
This is the American ICD-10-CM version of E71.511 – other international versions of ICD-10 E71.511 may differ.